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Abstract
Mutations causing replication stress can lead to genomic instability (GIN). In vitro studies have shown that drastic depletion
of the MCM2-7 DNA replication licensing factors, which form the replicative helicase, can cause GIN and cell proliferation
defects that are exacerbated under conditions of replication stress. To explore the effects of incrementally attenuated
replication licensing in whole animals, we generated and analyzed the phenotypes of mice that were hemizygous for Mcm2,
3, 4, 6, and 7 null alleles, combinations thereof, and also in conjunction with the hypomorphic Mcm4
Chaos3 cancer
susceptibility allele. Mcm4
Chaos3/Chaos3 embryonic fibroblasts have ,40% reduction in all MCM proteins, coincident with
reduced Mcm2-7 mRNA. Further genetic reductions of Mcm2, 6,o r7 in this background caused various phenotypes
including synthetic lethality, growth retardation, decreased cellular proliferation, GIN, and early onset cancer. Remarkably,
heterozygosity for Mcm3 rescued many of these defects. Consistent with a role in MCM nuclear export possessed by the
yeast Mcm3 ortholog, the phenotypic rescues correlated with increased chromatin-bound MCMs, and also higher levels of
nuclear MCM2 during S phase. The genetic, molecular and phenotypic data demonstrate that relatively minor quantitative
alterations of MCM expression, homeostasis or subcellular distribution can have diverse and serious consequences upon
development and confer cancer susceptibility. The results support the notion that the normally high levels of MCMs in cells
are needed not only for activating the basal set of replication origins, but also ‘‘backup’’ origins that are recruited in times of
replication stress to ensure complete replication of the genome.
Citation: Chuang C-H, Wallace MD, Abratte C, Southard T, Schimenti JC (2010) Incremental Genetic Perturbations to MCM2-7 Expression and Subcellular
Distribution Reveal Exquisite Sensitivity of Mice to DNA Replication Stress. PLoS Genet 6(9): e1001110. doi:10.1371/journal.pgen.1001110
Editor: Wayne N. Frankel, The Jackson Laboratory, United States of America
Received June 1, 2010; Accepted August 3, 2010; Published September 9, 2010
Copyright:  2010 Chuang et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This work was supported in part by a Department of Defense Breast Cancer Program predoctoral fellowship BC083376 to CC, a fellowship slot on
National Institutes of Health (NIH) training grant T31 GM7617 for MW, NIH grant R01GM45415 to JS, and a NYSTEM core grant to JS (http://stemcell.ny.gov/). The
funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: jcs92@cornell.edu
Introduction
In late mitosis to early G1 phase of the cell cycle, DNA
replication origins are selected and bound by the hexameric origin
recognition complex (ORC; [1]). ORC then recruits the initiation
factors CDC6 and CDT1, which are required for loading MCM2-
7, thereby forming the ‘‘pre-replicative complex’’ (pre-RC). The
formation of pre-RCs is termed origin ‘‘licensing’’ and this gives
origins competency to initiate a single round of DNA synthesis
before entering S phase. MCM2-7 is a hexamer of six distinct but
structurally-related minichromosome maintenance (MCM) pro-
teins (reviewed in [2–5]). In vivo and in vitro evidence indicates that
the MCM2-7 complex is the replicative helicase [6–8].
MCM2-7 proteins are abundant in proliferating cells [9], and
are bound to chromatin in amounts exceeding that which is
present at active replication origins or required for complete DNA
replication [10–14]. Although these and other studies showed that
drastic decreases in MCMs are tolerated by dividing cells, there
are certain deleterious consequences. In Xenopus extracts and
mammalian cells, excess chromatin-bound MCM2-7 complexes
occupy dormant or ‘‘backup’’ origins that are activated under
conditions of replication stress, compensating for stalled or
disrupted primary replication forks [11,15–16]. The depletion of
these backup licensed origins was associated with elevated
chromosomal instability and susceptibility to replication stress,
factors that might predispose to cancer.
In previous work, Shima et al found that a hypomorphic allele of
mouse Mcm4 (Mcm4
Chaos3) caused high levels of GIN and extreme
mammary cancer susceptibility in the C3HeB/FeJ background
[17]. This provided the first concrete evidence that endogenous
mutations in replication licensing machinery may have a causative
role in cancer development. The ethylnitrosourea (ENU)-induced
Mcm4
Chaos3 point mutation changed PHE to ILE at residue 345
(Phe345Ile). This amino acid is conserved across diverse
eukaryotes and is important for interaction with other MCMs
[18]. Budding yeast engineered to bear the orthologous mutation
exhibit DNA replication defects and GIN [17,19]. Surprisingly,
MEFs from Mcm4
Chaos3 mice not only had reduced levels of
MCM4, but also MCM7 [17], suggesting that the point mutation
might destabilize the MCM2-7 complex. Subsequently, it was
reported that mice containing 1/3 the normal level of MCM2
succumbed to lymphomas at a very young age, and had diverse
stem cell proliferation defects [20]. These mice also had 27%
reduced levels of MCM7 protein, and their cells exhibited
decreased replication origin usage when under replication stress
(treatment with hydroxyurea) conditions [21]. These studies imply
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sufficient to cause cancer susceptibility, developmental defects, and
GIN [20].
Here, we report that genetically-induced reductions of MCM
levels in mice, achieved by breeding combinations of MCM2-7
alleles, caused several health-related defects including increased
embryonic lethality, GIN, cancer susceptibility, growth retarda-
tion, defective cell proliferation, and hematopoiesis defects.
Remarkably, genetic reduction of MCM3, which mediates nuclear
export of excess MCM2-7 complexes in yeast [22], rescued many
of these defects, presumably attributable to observed increases in
chromatin-bound MCM levels. These data suggest that relatively
minor misregulation or destabilization of MCM homeostasis
can have serious consequences for health, viability and cancer
susceptibility of animals.
Results
Mcm4
Chaos3/Chaos3 cells exhibit pan-reduction of total and
chromatin-bound MCM2-7 due to decreased mRNA
levels
To extend previous findings that Mcm4
Chaos3Chaos3 cells exhibited
decreases in MCM4 and MCM7 protein, and to determine if the
decreased levels were differentially compartmentalized in the cell,
we quantified soluble and chromatin-bound MCM2-7 levels in
mouse embryonic fibroblasts (MEFs) by Western blot analysis. As
shown in Figure 1A, all MCMs were decreased in both
compartments by at least 40% compared to WT cells. Because
Mcm4
Chaos3/Chaos3 MEF cultures have slightly decreased prolifera-
tion and G2/M delay (Figure 1A and [17]), it is possible that the
lower MCM levels in mutant MEFs are entirely attributable to
growth defects. To test this, we assessed the levels of nuclear
MCM2 in S-phase cells by flow cytometry (Figure 1B). Although
MCM2 levels in WT and Mcm4
Chaos3/Chaos3 G1 nuclei were
essentially the same (P=.65; t-test), mutant cells transitioned from
G1 to S with 40% less nuclear MCM2 content than in WT
(P,.02; t-test). The levels of nuclear MCM2 in WT decreased
through S phase more sharply than in mutants, which transitioned
to G2 with only ,23% less than controls (Figure 1B). This
differential decline is apparent in the flow plots, where WT cells
exhibit a greater downward slope in the S compartment
(Figure 1B). The decreases in MCM2 from early to late S were
51% in WT and 38% in mutants. The MCM2 intra-S modulation
phenomenon is also addressed in subsequent experiments. The
marked differences in nuclear MCM2 concentration between
actively proliferating (S-phase) WT and mutant cells indicates that
a biochemical or regulatory basis, rather than a population
skewing, underlies the differences in protein levels.
Another possible explanation for the coordinated decrease in
MCMs is that the mutant MCM4
Chaos3 protein destabilizes the
MCM2-7 hexamer and causes subsequent degradation of
uncomplexed MCMs. Other groups reported that knockdown of
Mcm2, Mcm3, or Mcm5 in human cells decreased the amount of
other chromatin-bound MCMs [15–16], leading to a similar
proposition that the cause was MCM2-7 hexamer destabilization
[16]. If true, then we would expect mRNA levels to be unchanged
in mutant cells. To test this, we performed quantitative RT-PCR
(qRT-PCR) analysis of Mcm2-7, and several control housekeeping
genes in Mcm4
Chaos3/Chaos3 MEFs. Analysis of 5 littermate pairs of
primary MEF cultures revealed that transcript levels for each of
these genes in mutant cells was 51–65% of WT, similar to the
protein decreases (Figure 1C). Levels of mRNA in the 7
housekeeping genes analyzed were not altered significantly
(Figure 1C, right panel). This data suggest that either reduced
MCM4 levels per se, or defects resulting from the Mcm4
Chaos3 allele,
cause a decrease in the levels of all Mcm mRNAs. Interestingly,
the mRNA reduction appears to occur post-transcriptionally, a
phenomenon that is currently under investigation (Chuang and
Schimenti, unpublished observations).
Decreased Mcm gene dosages cause elevated
chromosomal instability and Mcm2-specific
pan-decreases in Mcm mRNAs
The Mcm4
Chaos3 allele was identified in a forward genetic screen
for mutations causing elevated micronuclei (MN) in red blood
cells, an indicator of GIN [17]. While the altered MCM4
Chaos3
protein may cause DNA replication errors as does a yeast allele
engineered to contain the same amino acid change [19], it is also
possible that the decrease in overall MCM levels in Mcm4
Chaos3
mutants contributes to, or is primarily responsible for, elevated S-
phase DNA damage and GIN as is seen in various cell culture
models (see Introduction). To test this possibility, we generated
mice from ES cells bearing gene trap insertions in Mcm2, Mcm3,
Mcm6, and Mcm7 (Figure 2A; alleles are designated as Mcm#
Gt).
These gene traps are designed to disrupt gene expression by fusing
the 59 end of the endogenous mRNA (via use of a splice acceptor)
to a vector-encoded reporter, resulting in a fusion protein lacking
the C-terminal portion of the endogenous (MCM) protein. As with
a previously-reported Mcm4 gene trap [17], each of these alleles
proved to be recessive embryonic lethal (Figure S1). Furthermore,
each allele appeared to be a null, since mRNA levels in
heterozygous MEF cultures were ,50% lower than WT controls
(Figure 2B). To determine if heterozygosity for various Mcms
caused pan-decreases in Mcm mRNA levels as does homozygosity
for Mcm4
Chaos3, mRNA levels for each of the Mcm2-7 genes were
also quantified. Whereas Mcm2
Gt/+ cells did show ,20% decreases
in the other Mcms, the Mcm3, Mcm4, Mcm6 and Mcm7 gene trap
alleles did not (Figure 2B). Thus, it appears that the marked Mcm
pan-decreases in Mcm4
Chaos3/Chaos3 cells are not due to decreased
Mcm4 RNA per se, but rather a response to replication defects cause
by the mutant protein. Notably, the pan Mcm2-7 downregulation
in Mcm2
Gt/+ cells is consistent with the observation that MCM7 is
Author Summary
Proper replication of the genome is essential for mainte-
nance of the genetic material and normal cell proliferation.
DNA replication can be compromised by exogenous
factors and genetic disruptions. Such compromise can
lead to disease such as cancer, which is characterized by
genomic instability (an elevated mutation rate). Because
the DNA replication apparatus is essential, relatively little is
known about how genetic variants impact the health of
whole animals. In this report, we studied mice bearing
combinatorial mutations in a component of the replication
apparatus, the MCM2-7 helicase. MCM2-7 is a complex of 6
proteins that are essential for initiating DNA replication
along chromosomes, and to unwind the DNA during DNA
replication. We find that although cells have excess
amounts of MCM2-7 to support proliferation under normal
circumstances, that incremental MCM depletions have
multiple drastic effects upon the whole animal, including
embryonic lethality, stem cells defects, and severe cancer
susceptibility. Additionally, we report that mouse cells
regulate and coordinate the levels of usable MCM proteins,
both at the level of synthesis and also by regulating access
to chromatin. The implication is that genetic variants that
impact MCM levels, even to a minor degree, can translate
into disease.
Quantitative Mcm Perturbation in Mice
PLoS Genetics | www.plosgenetics.org 2 September 2010 | Volume 6 | Issue 9 | e1001110Figure 1. MCM2-7 proteins and mRNA are reduced in Mcm4
Chaos3/Chaos3 MEFs, particularly in early S phase. (A) Western blot analysis of
MCM2-7 (left panel). Soluble or chromatin-bound protein was electrophoresced on PAGE gels, electrotransferred, and the blots were immunolabeled
with the indicated antibodies. The bands correspond to the predicted molecular weights of these proteins, and for MCM2, the identity of the band
was verifed by RNAi knockdown and transient overexpression in NIH 3T3 cells. TBP=TATA box binding protein. Quantification of Western blot data
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IRES-CreERT2/IRES-CreERT2 mice, although mRNA
levels were not evaluated in that study [20].
After breeding the gene trap alleles into the C3HeB/FeJ genetic
background for at least 2 generations (Mcm4
Chaos3/Chaos3 females get
mammary tumors in this background), blood MN levels were
measured. Heterozygosity for each allele caused an increase in the
fraction of cells with MN (Figure 2C). Compound heterozygosity
further increased MN on average, as did heterozygosity for 3 or
more gene traps (Figure 2C), indicating that genetically-based
decreases in any of the MCMs precipitate GIN.
Genetic reductions of Mcm2, Mcm6 or Mcm7 in an
Mcm4
Chaos3/Chaos3 background causes partial synthetic
lethality, severe growth defects and (for Mcm2)
dramatically accelerated cancer onset
As outlined above, previous studies showed that reductions of
particular MCMs in cells or mice reduces the levels of other MCMs,
causing GIN, cancer, and developmental defects. However, the
reduction in MCM levels required to precipitate these consequences,
and whether there is a threshold effect, is unclear. To explore the
consequences of incremental MCM reductions on viability and
cancer in mice, we crossed the Mcm4
Chaos3 and gene trap alleles into
the same genome. In the caseof Mcm2,therewasastrikingandhighly
significant shortfall of Mcm4
Chaos3/Chaos3 Mcm2
Gt/+ offspring at birth
(Figure 3A; Figure S2). Heterozygosity for Mcm2
Gt itself was not
haploinsufficient, as indicated by Mendelian transmission of Mcm2
Gt
in crosses of heterozygotes to WT (119/250; x
2=0.448). These
results demonstrate that thereis a synthetic lethal interaction between
Mcm4
Chaos3 and Mcm2
Gt that is related to MCM2 levels. Additionally,
the surviving Mcm4
Chaos3/Chaos3 Mcm2
Gt/+ offspring were severely
growth retarded; males weighed ,50% less than Mcm4
Chaos3/Chaos3
siblings (Figure 3B; this genotype causes disproportionate female
lethality). Another indication of a quantitative MCM threshold effect
is that C3H-Mcm4
Chaos3/Chaos3 mice are developmentally normal, but
Mcm4
Chaos3/Gt animals die in utero or neonatally (Figure 3A) [23].
The synthetic interaction between Mcm4
Chaos3 and Mcm2
Gt might
be specific, or it may reflect a general consequence of reduced
replication licensing (and consequent elevated replication stress).
We therefore testedwhether hemizygosity forMcm3,Mcm6orMcm7
would also cause synthetic phenotypes in the Mcm4
Chaos3/Chaos3
background. The Mcm4
Chaos3/Chaos3 Mcm6
Gt/+ genotype caused
highly penetrant embryonic lethality; only 10% of the expected
number of such animals survived to birth (Figure 3A; Figure S2).
The Mcm4
Chaos3/Chaos3 Mcm7
Gt/+ genotype caused both embryonic
and postnatal lethality. The number of liveborns was ,50% of the
expected value, and only 8% of those (5/62) survived to weaning
(Figure 3A;Figure S2). Additionally, as with Mcm2, hemizygosityfor
Mcm6
Gt and Mcm7
Gt in the Mcm4
Chaos3/Chaos3 background caused
growth retardation (Figure 3B). The decrease in male weight was
,20% and ,80% respectively, compared to Mcm4
Chaos3/Chaos3
siblings at the oldest age measured (Mcm4
Chaos3/Chaos3 Mcm7
Gt/+
animals died before wean, so the oldest weights were taken at
10 dpp). In contrast to the synthetic phenotypes with Mcm2, 4, 6
and 7, there was no significant decrease in viability (Figure 3A) or
weight (not shown) in Mcm4
Chaos3/Chaos3 Mcm3
Gt/+ mice. This
seeming inconsistency is addressed in the following section.
As mentioned earlier, mice with ,35% of WT MCM2 protein,
but not 62%, showed early latency (10–12 week) lymphoma
susceptibility [20]. To identify if there is a critical MCM threshold
for cancer susceptibility, we aged a cohort of Mcm2
Gt/+ mice,
representing approximately intermediate MCM2 levels. As shown
in Figure 4A, these animals did not show a dramatic cancer-
related mortality in the first 12 months of life. However, we did
find that ,3/4 of these animals had tumors at death or necropsy
by 18 months of age (data not shown). These combined data are
suggestive of a potential gradient of susceptibility, but that there is
a critical minimum threshold of MCM levels, between ,35 and
50% in the case of MCM2, required to avoid early cancer and
other developmental defects.
To further resolve this phenomenon, surviving Mcm4
Chaos3/Chaos3
Mcm2
Gt/+ mice were aged and monitored. They began dying at 2
months of age, and all were dead (or sacrificed when they
appeared moribund) by 7 months (Figure 4A). Gross necropsy and
histopathological analyses revealed or suggested lymphomas/
leukemias in 20 of these animals (summarized in Table S1 with
histological examples in Figure S3; detailed histopathology analysis
of a T cell leukemic lymphoma is presented in Figure 4B). Six of
these had chest tumors that were likely thymic lymphomas. The
cause of death for the remaining 7 animals was undetermined.
Consistent with previous studies [17], most Mcm4
Chaos3/Chaos3 mice
hadn’t yet succumbed from tumors or other causes by 12 months
of age. Additional animals of these genotypes are incorporated in
Figure 6, but histopathological analyses weren’t conducted. These
data show clearly that removing a half dose of MCM2 from
Mcm4
Chaos3/Chaos3 cells is sufficient to produce greatly elevated
cancer predisposition to the already-underrepresented survivors at
wean. Mcm4
Chaos3/Chaos3 Mcm2
Gt/+ MEFs had 45% the amount of
Mcm2 mRNA as Mcm4
Chaos3/Chaos3 cells (Figure 7C), which already
had a 38% reduction compared to WT (Figure 1). Thus, Mcm2
RNA was reduced to ,17% of WT. To determine if elevated GIN
might be responsible for the cancer susceptibility phenotype, we
measured erythrocyte MN. Whereas the percentage of micro-
nucleated RBCs in Mcm4
Chaos3/Chaos3 mice was 4.1860.26
(mean6SEM, N=12), Mcm4
Chaos3/Chaos3 Mcm2
Gt/+ mice averaged
5.8560.47 (N=16), indicating a synergistic increase (P,0.01).
Overall, the data support the notion that in whole animals,
reduction of MCMs to under 50% of WT causes severe
developmental and physiological problems.
Rescue of phenotypic defects in Mcm4
Chaos3/Chaos3 and
Mcm4
Chaos3/Chaos3 Mcm2
Gt/+ mice by reducing Mcm3
genetic dosage
The data reported here and elsewhere [17,20] support a model
where phenotypic severity is proportionally related to MCM
by densitometry is shown in the center panel. The amounts relative to WT cells (after normalization to the controls) are plotted. Error bars represent
SEM, derived from 4 replicate experiments. The rightmost panel graphs the results of flow cytometric analysis of unsynchronized MEF culture cell
cycle profiles, based on DNA content. (B) Flow cytometric quantification of MCM2 content (fluorescence intensity of antibody staining) is plotted on
the Y axis, vs DNA content on the X axis. Plotted at the right is the mean fluorescent intensity of the 3 gated (boxed) regions from the flow data.
Se=early S phase; SL=late S phase. The labeled cell cycle stages are based on DNA content. However, because light scatter was inadequate to
distinguish individual nuclei from clumped nuclei or artifactual structures, the 4c category (denoted G2/M*) contains events other than G2/M nuclei.
*We drew a dashed line representing an arbitrary cutoff above which contains such undefined events. (C) qRT-PCR analysis of Mcm mRNAs (left
panel) and control genes (right panel), in the three indicated genotypes of MEFs. Relative transcript levels were normalized to b-actin. Charted are the
percent levels of the indicated RNAs in mutant compared to WT (considered to be 100%). At least 3 replicate cultures were analyzed for each
genotype. Error bars are SEM. In all panels, the raw data shown are from MEFs established from littermates. Furthermore, the replicates involved MEFs
from pairs of littermates. Chaos3=Mcm4
Chaos3/Chaos3;W T=+/+.
doi:10.1371/journal.pgen.1001110.g001
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notable exception: hemizygosity for Mcm3 did not cause any severe
haploinsufficiency phenotypes (increased lethality and decreased
weight) as did Mcm2/6/7 in the Mcm4
Chaos3/Chaos3 background, or
Mcm4
Gt in trans to Mcm4
Chaos3 (Figure 3A; Figure S2). Since
extreme reductions of MCM3 in cultured human cells caused GIN
and cell cycle arrest [16], the absence of synthetic effects with
Mcm
Chaos3 led us to hypothesize that either mice are more tolerant
to lower levels of this particular MCM, or that MCM3 is present
in a stoichiometric excess compared to the other MCMs, at least in
a subset of cell types. To explore these issues we performed
additional phenotype analyses, and also sought to uncover
potential effects of MCM3 reduction by reducing other MCMs
simultaneously.
Strikingly, rather than exacerbating the synthetic lethality in
Mcm4
Chaos3/Chaos3 Mcm2
Gt/+ mice, Mcm3
Gt heterozygosity signifi-
cantly rescued their viability to 72.5% from 29.7% (Figure 5A and
Fig S3). Not only was viability rescued, but also growth (weight) of
Figure 3. Synthetic lethality and growth retardation between Mcm4
Chaos3 and Mcm2, Mcm6 and Mcm7. (A) Graphed are viability data from
crosses presented in Figure S2, which includes statistics. Unless otherwise indicated, the values represent expected proportions of indicated
genotypes that were present at wean. (B) Weights of surviving animals are graphed over time. SEM bars are shown.
doi:10.1371/journal.pgen.1001110.g003
Figure 2. Mcm gene trap alleles and associated mRNA levels, peripheral blood micronuclei, and cancer frequency. (A) Genomic
structures of mutated Mcm genes. Indicated is the intron/exon structure of each gene (not to scale), the locations of the gene trap insertions, and
qPCR primer locations. (B) qRT-PCR analyses of MEF mRNA from gene trap heterozygotes. Charted are the percent levels of the indicated RNAs in
mutant compared to WT (considered to be 100%). For all but Mcm7, the data were obtained from at least 3 MEF cultures from different embryos. The
Mcm7 data represents the average of three replicates from 1 MEF culture, hence there are no error bars. Otherwise, error bars show SEM. (C)
Micronucleus levels in Mcm gene trap-bearing male mice. At least 5 animals were analyzed for each single gene trap mutant allele. The ‘‘2GT’’ (two
gene trap) group contains: 4 mice doubly heterozygous for Mcm2
Gt and Mcm3
Gt (‘‘Mcm2/3’’), 4 Mcm2/4 mice, and 4 Mcm3/4 mice. The 3GT group
contains: 4 Mcm2/3/4 mice, 1 Mcm2/3/6 mouse, 1 Mcm2/4/6 mouse, and 3 Mcm3/4/6 mice. The 4-5GT group contains: 3 Mcm2/3/4/6 mice, 1 Mcm2/
3/6/7 mouse, and 2 Mcm2/3/4/6/7 mouse. SEM bars are shown.
doi:10.1371/journal.pgen.1001110.g002
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Chaos3/Chaos3 Mcm2
Gt/+ Mcm3
Gt/+ survivors compared to
Mcm4
Chaos3/Chaos3 Mcm2
Gt/+ animals produced from the same
matings (Figure 5B). Mcm3 hemizygosity also significantly rescued
the near 100% lethality of Mcm4
Chaos3/Gt animals (nearly 6 fold
increased viability), and doubled the viability of Mcm4
Chaos3/Chaos3
Mcm6
Gt/+ mice (Figure 5A; Figure S3). Rescue of Mcm4
Chaos3/Chaos3
Mcm7
Gt/+ was not observed (not shown).
The rescue of the reduced growth phenotype by Mcm3
hemizygosity led us to evaluate the proliferation of compound
mutant cells. Whereas Mcm4
Chaos3/Chaos3 and Mcm4
Chaos3/Chaos3
Mcm3
Gt/+ primary MEFs proliferated at identical rates,
Mcm4
Chaos3/Chaos3 Mcm2
Gt/+ MEFs showed a severe growth defect
beginning ,5 days in culture (Figure 5C). As with whole animals,
MEF growth was partially but significantly rescued by Mcm3
hemizygosity.
Since the Mcm4
Chaos3 and Mcm2
Gt alleles causes elevated GIN
(micronuclei in RBCs), we considered the possibility that the Mcm3
rescue effect might be related to an attentuation of GIN. Accordingly,
Figure 4. Premature morbidity and cancer susceptibility in Mcm4
Chaos3/Chaos3 Mcm2
Gt/+ mice. (A) Kaplan-Meier survival plot of the indicated
genotypes. Animals of both sexes are combined. ‘‘C3’’=Chaos3. (B) Spleen and liver histopathology of a Mcm4
C3/C3 Mcm2
Gt/+ male diagnosed with T
cell leukemic lymphoma. i. H&E stained spleen. Neoplastic cells have abundant cytoplasm, 1–2 nucleoli and a high mitotic rate, consistent with
lymphoblastic lymphoma. Bar=20 mm. ii. Neoplastic cells in spleen demonstrate immunoreactivity with anti-CD3 (brown; immunoperoxidase
staining with DAB chromogen & hematoxalin counterstain), indicating T lymphocytes. Bar=200mm. iii. In spleen, immunoreactivity (brown) with anti-
PAX-5 (a B cell marker) is limited to follicular remnants and scattered individual cells. Bar=200 mm. iv. In liver, neoplastic cells surround central veins
and expand sinusoids (see also Figure S4) and demonstrate immunoreactivity (brown) with the anti-CD3 T lymphocyte marker. Bar=50 mm.
doi:10.1371/journal.pgen.1001110.g004
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PLoS Genetics | www.plosgenetics.org 7 September 2010 | Volume 6 | Issue 9 | e1001110Figure 5. Rescue of phenotypes by Mcm3 hemizygosity. (A) Heterozygosity for Mcm3
Gt rescues the low viability of various mutant genotypes
(asterisk indicates significance at P,0.05 by FET). The raw data are presented in Figure S4. (B) Male body weights of combination mutant mice. The
weights of Mcm4
Chaos3/Chaos3 Mcm2
Gt/+ Mcm3
Gt/+ mice are significantly higher (asterisk; P,0.01, Student’s t-test) at 90 days than Mcm4
Chaos3/Chaos3
Quantitative Mcm Perturbation in Mice
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Chaos3/Chaos3 mice with different
combinations of other Mcm mutations. As shown in Figure 5D,
hemizygosity for Mcm2 and Mcm7 caused a significant elevation in
MN levels, unlike Mcm3. However, the increased MN in
Mcm4
Chaos3/Chaos3 Mcm2
Gt/+ was not rescued by Mcm3 hemizygosity.
This suggests that the synthetic lethality and mouse/cell growth defects
are not related to GIN per se. However, in the course of measuring MN
in enucleated peripheral blood cells, we noticed that the ratio of
CD71+ cells was significantly higher in both Mcm4
Chaos3/Chaos3
Mcm2
Gt/+ and Mcm4
Chaos3/Chaos3 Mcm7
Gt/+ mice (3.3 and 6.2 fold,
respectively; Figure 5E). This increase in the ratio of reticulocytes
(erythrocyte precursors; immature RBCs) to total RBCs is character-
istic of anemia. Hemizygosity for Mcm3, which alone had no effect on
CD71 ratios of Chaos3 mice, corrected completely this abnormal
phenotype in Mcm4
Chaos3/Chaos3 Mcm2
Gt/+animals (Figure 5E).
Because MCM2-depleted mice were reported to have stem cell
defects [20], and Mcm4
Chaos3/Chaos3 Mcm#
Gt/+ mice had clear
developmental abnormalities, we examined the efficiency of
reprogramming mutant MEFs into induced pluripotent stem cells
(iPS). The efficiency was quantified using either : 1) iPS-like colony
formation, or 2) cells counts of SSEA1 and LIN28 positive cells by
flow cytometry. Both gave similar results. Mcm4
Chaos3/Chaos3 Mcm2
Gt/+
cells were severely compromised in the ability to form iPS cells
compared to Mcm4
Chaos3/Chaos3 (,200 fold less efficient; Figure 5F).
However, additionally reducing Mcm3 by 50% increased iPS
formation from both Mcm4
Chaos3/Chaos3and Mcm4
Chaos3/Chaos3
Mcm2
Gt/+ MEFs by ,2.5 and 10 fold, respectively.
Finally, we found that reduced MCM3 levels could rescue the
cancersusceptibilityoftwodifferentChaos3models.Asshownearlier
(Figure 4), Mcm4
Chaos3/Chaos3 Mcm2
Gt/+ mice were highly cancer-prone
with an average latency of ,4 months. When a dose of Mcm3 was
removed from mice of this genotype, lifespan was extended
dramatically in both sexes as a consequence of delayed cancer onset,
and the cancer spectrum shifted from lymphoma/thymoma towards
mammary tumors (Figure 6A). Additionally, hemizygosity of Mcm3
delayed (or eliminated) the onset of mammary tumorigenesis in
Mcm4
Chaos3/Chaos3 females by ,4 or more months (Figure 6B).
However, although Mcm3 hemizygosity rescued viability of
Mcm4
Chaos3/Gt mice (Figure 5A), these animals were cancer prone
with a shorter latency (by ,6 months) and different spectrum
(primarily lymphomas) than Mcm4
Chaos3 homozygotes.
Decreased MCM3 increases chromatin-bound levels of
other MCMs
We considered two possibilities to explain the surprising
phenotypic rescues of reduced MCM genotypes (Mcm4
Chaos3/Chaos3 ;
Mcm4
Chaos3/Chaos3 Mcm2/6
Gt/+ ; Mcm4
Chaos3/Gt) by additional MCM3
reduction (Mcm3
Gt/+). One is that the phenotypes are related to
altered stoichiometry of MCM monomers, and that disproportionally
high amounts of MCM3 relative to MCM4 and MCM2/6/7 have a
dominant negative effect. However, as demonstrated above, levels
of MCM3 are proportionally reduced in Mcm4
Chaos3/Chaos3 cells
(Figure 1). The second possibility is that decreased levels of MCM3
leads to a favorable change in the amounts or subcellular localization
of MCMs. Various experiments have indicated that MCM2-7
hexamers or subcomplexes must be assembled in the cytoplasm
before nuclear import in yeast [4], and in mice, nuclear import
appears to require MCM2 and MCM3 [24]. MCMs shuttle between
the nucleus and cytoplasm during the cell cycle in S. cerevisiae.
Although in most other organisms MCMs are reported to be
predominantly and constitutively nuclear localized throughout the
cell cycle, dynamic redistribution between the nucleus and cytoplasm
has been observed in hormonally-treated mouse uterine cells [25]. In
budding yeast, nuclear export is dependent upon Mcm3, which has a
nuclear export signal (NES) that is recognized by Cdc28 to promote
export ofMCM2-7[22]. Analysis of mouse and human MCM3using
NES prediction software (www.cbs.dtu.dk/services/NetNES/) [26]
revealed the presence of homologously-positioned, leucine-rich
potential NESs (Figure 7A). Therefore, we hypothesized that the
rescue of phenotypes by Mcm3 hemizygosity is due to decreased
MCM protein export from the nucleus, or alternatively, increased
nuclear import or stabilization that allows greater accessof allMCMs
for licensing chromatin.
To explore this hypothesis, we performed Western blot analysis
of MCM levels in Mcm4
Chaos3/Chaos3 MEFs with or without the
Mcm3
Gt and/or Mcm2
Gt alleles, and examined the effects of Mcm3
dosage on the levels of nuclear and chromatin-bound MCM2 and
MCM4. The results are presented in Figure 7B. In all cases, the
genetic reductions of Mcm2 and Mcm3 led to corresponding
decreases in the cognate mRNA levels (Figure 7C), with only
minor additional decreases of other MCM mRNAs (beyond that
already caused by homozygosity for Mcm4
Chaos3) occuring in the
context of Mcm2 hemizygosity (similar to Mcm2
Gt/+ MEFs in
Figure 2B). The overall levels of total, nuclear, and chromatin-
bound MCM2 and MCM4 were unaffected by hemizygosity of
Mcm3 in Mcm4
Chaos3/Chaos3 cells (Figure 7B). When Mcm2 levels
were genetically reduced by half, a condition causing the severe
phenotypic effects described earlier, this caused a marked
decrease in the level of chromatin-bound MCM3 and MCM4
(in addition to MCM2 itself), although total and nuclear MCM3/
4 levels were affected to a lower degree or not at all. Strikingly,
the decreased levels of chromatin-bound MCM2/3/4 in
Mcm4
Chaos3/Chaos3 Mcm2
Gt/+ MEFs were reversed by Mcm3
heterozygosity, but levels of total MCM2 and MCM4 were not
restored. The increase of chromatin-bound MCMs occured
despite the presence of less MCM3, suggesting that MCM3 is
present at levels in excess of that needed to bind chromatin,
presumably for pre-RC formation in the context of the MCM2-7
hexamer. In conclusion, a 50% reduction in total MCM3
increases MCM2/4 loading onto chromatin when MCM2 is
otherwise limiting, and this rescue is associated with amelioration
of several phenotypes.
We found that elevation of nuclear MCMs in the Mcm3
Gt/+ MEFs
was often (as shown in Figure 7B), but not consistently elevated across
Mcm2
Gt/+ mice. Error bars represent SEM. (C) Mcm4
Chaos3/Chaos3 Mcm2
Gt/+ MEF proliferation defects are partially rescued by Mcm3 hemizygosity. The
effect is significant after 6 days in culture (P,0.05, Student’s t-test; Error bars represent SEM). (D) Micronucleus levels in Mcm4
Chaos3/Chaos3 mice
bearing additional gene trap alleles. At least 5 males were analyzed for each genotype. Error bars represent SEM. Asterisk indicates P,0.05 (student’s
t-test.) compared to Mcm4
Chaos3/Chaos3 alone. (E) CD71+ reticulocyte ratios in mutant male mice. At least 5 animals were analyzed from each class. The
samples are identical to those in ‘‘D’’. All scored cells were anucleate peripheral blood cells Error bars represent SEM. Asterisks and ‘‘#’’ indicate
P,0.05 (Student’s t-test) when compared to Mcm4
Chaos3/Chaos3 and Mcm4
Chaos3/Chaos3 Mcm2
Gt/+ cohorts, respectively. (F) Mcm2 hemizygosity
decreases efficiency of reprogramming Mcm4
Chaos3/Chaos3 MEFs into iPS cells, and Mcm3 hemizygosity significantly increases reprogramming
efficiency. Two methods of quanitifying reprogramming were used as described in Materials and Methods. ‘‘Cell number’’ refers flow cytometric
quantification of LIN28/SSEA1 double positive cells from primary cultures of reprogrammed MEFs. Relative reprogramming efficiencies were
normalized to Mcm4
Chaos3/Chaos3 MEFs (considered to be 100%). Error bars represent SEM. All samples within quantification class are significantly
different from one another (P,0.05, Student’s t-test). C3=Mcm4
Chaos3;M=Mcm.
doi:10.1371/journal.pgen.1001110.g005
Quantitative Mcm Perturbation in Mice
PLoS Genetics | www.plosgenetics.org 9 September 2010 | Volume 6 | Issue 9 | e1001110samples by Western analysis (not shown). Therefore, we quantified
MCM2 during the cell cycle by flow cytometric analysis of nuclei from
7 replicate MEF cultures. Similar to WT MEFs (examples in
Figure 1B), NIH3T3 cells showed a decrease of nuclear MCM2
during S phase progression (Figure 7D, left panel). However, all
genotypes with in the Mcm4
Chaos3/Chaos3 background had a reduced
decline. Thus, for comparative quantitation across genotypes, we
compared the levels of MCM2 levels at the beginning of G1 vs. that in
S phase (regions used for these calculations are indicated in the left
panel), using the calculation described in the Figure 7 legend. The data
are graphed in the right panel. The data revealed that regardless of
genotype, the difference in average amounts of nuclear MCM2 at the
beginning and end of G1 (DG1) did not vary. Compared to
Mcm4
Chaos3/Chaos3,c e l l sl a c k i n g1d o s eo fMcm2 had relatively lower
levels of S phase MCM2 (DS) compared to early G1. Additional
removal of an Mcm3 dose partially rescued the DSvalue,indicating that
these cells had ,16% more nuclear MCM2 in S phase compared to
Mcm4
Chaos3/Chaos3 cells hemizygous for Mcm2 alone, despite overall
reduced MCM2 levels in the cell (Figure 7B, left panel).
Discussion
MCM2-7 proteins exist abundantly in proliferating cells and are
bound to chromatin in amounts exceeding that required to license
all replication origins that initiate DNA synthesis [9–12,14]. The
role of excess chromatin-bound MCM2-7 has been a mystery
referred to as the ‘‘MCM paradox’’ [27], perpetuated by
observations that drastic MCM reductions in certain systems can
be compatible with normal DNA replication or cell proliferation
[13,28–30]. However, these circumstances are not universal, and
reductions are not entirely without consequences. Early studies
showed that a reduction in MCMs resulted in decreased usage of
certain ARSs [12] and conferred genome instability [31] in yeasts.
In cell culture systems, depletion of certain MCMs have been
found to cause cell cycle defects, checkpoint abberations and GIN
[13,16–17,29,32].
Recent work has shed light on aspects of the MCM paradox.
Using Xenopus egg extracts attenuated for licensing by addition of
geminin (an inhibitor of CDT1, which is required for MCM
loading onto origins), one study proposed that excess chromatin-
bound MCM2-7 complexes license ‘‘dormant’’ origins that can be
activated to rescue stalled or damaged replication forks, a situation
that can become important under conditions of replication stress
[11]. Similar results were subsequently reported for human cells
depleted of MCMs by siRNA [15–16], and for replication stressed
MCM2-deficient MEFs [21]. Our finding that nuclear MCM2
levels decrease as S-phase progresses, and moreso in WT than in
Mcm4
Chaos3/Chaos3 MEFs, is consistent with the dormant origin
hypothesis. The decrease may reflect displacement of dormant
hexamers by active replisomes, followed by subsequent degrada-
Figure 6. Inhibition of Chaos3 cancers by MCM3 reduction. (A) Kaplan-Meier graphs of cohorts of the indicated genotypes. C3=Mcm4
Chaos3;
M#=Mcm#
Gt. In the left panel, the experiment was terminated at 12 months, with ,1/3 animals tumor-free and healthy at the time (see ‘‘B’’). Unless
otherwise indicated, the cohorts contained both sexes. (B) Pie charts of cancer types in mice from ‘‘A.’’ COD=cause of death; Unkn=unknown.
Classification of cancer types was assigned during necropsy, not from histological analysis.
doi:10.1371/journal.pgen.1001110.g006
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PLoS Genetics | www.plosgenetics.org 10 September 2010 | Volume 6 | Issue 9 | e1001110Figure 7. MCM3 regulates nuclear and chromatin-bound MCM levels. (A) Predicted nuclear export sequences (NES) in mouse MCM3 (see
text). (B) Western blot analysis of MCM2/3/4 in the indicated genotypes of MEFs. Three different protein fractions were examined, with the indicated
(arrow) loading controls at the bottom. (C) qRT-PCR analysis of Mcm2-7 mRNAs in MEFs of the indicated genotypes. (D) Nuclear MCM2 dynamics
during the cell cycle. The flow plot is of isolated nuclei stained for DNA content (PI=propidium iodide) on the X-axis, and MCM2 on the Y-axis. NIH3T3
cells show dramatically the decrease in nuclear MCM2 through S phase. Flow cytometric data from the 4 MEF genotypes indicated in the right panel
were used to calculate two values, DG1 and DS. The regions for the calculation of these values are indicated, and the values plotted in the right panel.
The G1 (1N DNA content) phase nuclei were divided into two equal groups based on MCM2 signal intensity (Y-axis): the lower half, considered to be
early-G1, and the upper half, considered to be late-G1. The DG1 value was calculated as the difference between the early and late MCM2 signal
intensity averages. The DS value was calculated as : (average MCM2 intensity in the S population) – (early G1 average intensity). C3=Mcm4
Chaos3;
M=Mcm. C3 is set at 100%. The asterisk indicates significance by Student’s t-test (P,0.05).
doi:10.1371/journal.pgen.1001110.g007
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origins than Chaos3 mutants, then WT cells would be expected
show a greater loss of MCMs.
The isolation of Mcm4
Chaos3 provided the first demonstration
that mutant alleles of essential replication licensing proteins can
cause GIN and cancer [17]. Diploid budding yeast containing the
same amino acid change in scMcm4 as the mouse Mcm4
Chaos3
exhibited Rad9-dependent G2/M delay (Rad9 is a DNA damage
checkpoint protein), elevated mitotic recombination, chromosome
rearrangements, and intralocus mutations [19] (Li, X. and Tye, B.,
personal communication). One explanation for these outcomes is
that the Chaos3 mutation impairs MCM4 biochemically in a
manner leading to elevated replication fork defects, and that these
defects lead to the GIN and cancer phenotypes. Alternatively,
and/or in addition, the observed associated pan-reductions of
MCMs in mouse cells [17] raised the possibility that decreased
replication licensing might be the primary or ancillary cause for
the mouse phenotypes.
The subsequent finding that mice (Mcm2
IRES-CreERT) containing
,1/3 the normal level of MCM2 had GIN and and cancer lent
support for the idea that reductions in MCMs contribute to the
Chaos3 phenotypes [20]. Although amounts of all MCMs were
not investigated in Mcm2
IRES-CreERT/IRES-CreERT mice, 65% reduc-
tion of MCM2 caused a reduction of dormant replication origins
in MEFs that were replication stressed by hydroxyurea [21]. In
Mcm4
Chaos3/Chaos3 mice, we hypothesize that in the context of
Mcm2, 6 or 7 heterozygosity, which further reduces overall and
chromatin-bound MCM levels below that already caused by
Mcm4
Chaos3 (measured to be ,20% of WT mRNA levels for
Mcm2), MCMs are reduced to a degree that compromises cell
proliferation. This then translates into the various developmental
defects and increased cancer susceptibility we observed. Whatever
the exact mechanistic cause of these phenotypes, it is clear that the
phenotypes are related to reduction of one or more MCMs below
a threshold level that is ,50%. The severe developmental
consequences of MCM depletion in mice suggests that certain
cell types in the developing embryo are highly sensitive to the
effects of replicative stress, and/or that relatively minor cell growth
perturbations of such cells are not well-tolerated in the context of
complex, rapidly-occuring developmental events. The molecular
basis for these phenotypes does not appear to be directly related to
GIN, because whereas Mcm3 hemizygosity rescued several
phenotypes, and delayed cancer latency in Mcm4
Chaos3/Chaos3 mice,
it did not concommitantly decrease MN. This suggests that
phenotypes such as decreased proliferation and embryonic death
are caused by genetically-induced replication stress, moreso (or in
addition to) than GIN alone.
Our genetic studies indicate that there is a quantitative MCM
threshold required for embryonic viability, as demonstrated by
the synthetic lethalities we observed when combining homozy-
gosity of Mcm4
Chaos3 with Mcm2
Gt, Mcm6
Gt or Mcm7
Gt heterozy-
gosity, but not in the heterozygous single mutants. Additionally,
the Mcm4
Chaos3/Gt genotype, which reduced MCM levels below
50%, caused embryonic and neonatal lethality [17]. Underscor-
ing the exquisite sensitivity of whole animals to subtle
perturbations in the DNA replication machinery were the
remarkable phenotypic rescues (viability, growth, iPS efficiency,
etc.) by Mcm3 hemizygosity. The decreased MCM dosage led to
increases in S phase nuclear MCMs and chromatin-bound
MCMs, presumably reflecting increased replication origin
formation. The various single and compound mutants described
here and elsewhere [20], which show that 50% reductions of any
one MCM is well-tolerated but decreases of ,2/3 are not,
supports the idea of a threshold effect, and suggests that the
threshold lies somewhere between 1/3 and 1/2 of normal MCM
levels (at least in the cases of MCM2, MCM6 and MCM7).
These results also emphasize the importance of relevant
physiological models, both in general and with respect to the
MCMs. RNAi knockdown of MCM3 in human cells to ,3%
normal levels was still compatible with normal short-term
proliferation, although the cells had GIN and high sensitivity to
replication stress [16]. It is doubtful such a drastic situation would
be recapitulated in vivo (it would likely result in embryonic lethality
as in Mcm3
Gt/Gt mice). Nevertheless, it is noteworthy in that study
that MCM3 depletion was better tolerated than knockdowns of
any other member of the replicative helicase.
The finding that reductions in MCM3 rescued MCM2/4/6
depletion phenotypes lends insight into dynamics and regulation of
mammalian DNA replication. In budding yeast, MCMs shuttle
between the nucleus and cytoplasm during the cell cycle. MCM2-7
multimers must be assembled in the cytoplasm before being
imported into the nucleus during G1 phase [4]. The MCM2-7
importation is dependent upon synergistic nuclear localization
signals (NLS) on Mcm2 and Mcm3 [22]. In order to prevent over-
replication of the genome, MCMs are exported from the nucleus
during S, G2 and M [4]. This export is dependent upon Mcm3,
which has a nuclear export signal (NES) that is recognized by
Cdc28 to promote MCM2-7 export in a Crm1-dependent manner
[22].
In contrast to budding yeast, MCMs that have been studied
(MCM2/3/7) are primarily nuclear-localized throughout the cell
cycle in metazoans and in fission yeast [4]. Upon dissociation from
chromatin during S phase, MCM2-7 complexes are reported to
remain in the nucleus but are sequestered via attachement to the
nuclear envelope or other nuclear structures [24,33–35]. Interest-
ingly, mcm mutations in fission yeast that disrupt intact MCM2-7
heterohexamers triggers active redistribution of MCMs to the
cytoplasm [36]. Additionally, re-distribution of MCMs between
the cytoplasmic and nuclear compartments has been observed in
hormonally-treated mouse uterine cells [25].
Our observations support the idea that intracellular re-
distribution of MCMs also occurs in mammals, and that it is an
important regulatory process. Staining of MCM2 in intact nuclei
of normal NIH 3T3 fibroblasts and MEFs show a steady decline
(but not elimination) as S phase progresses. Furthermore, it
appears that the process of nuclear MCM2 elimination during S
phase is regulated, since in situations of decreased MCMs (as in
the Mcm4
Chaos3/Chaos3 mutant), there is decreased loss of nuclear
MCM2 during S phase.
Three lines of experimentation implicate MCM3 as playing a
key role in regulating intracellular MCM localization: 1) Rescue of
reduced-MCM phenotypes by genetic reduction of MCM3; 2)
Increased S-phase nuclear MCM2 by Mcm3 hemizygosity in
MCM-depleted cells (Figure 7D); and increased chromatin-bound
MCM2/4 by Mcm3 hemizygosity in MCM-depleted cells. Our
data suggests that MCM3 acts as a negative regulator that
prevents re-assembly or reloading of MCM complexes as they
dissociate from DNA during replication. As described earlier,
mouse and human MCM3 have predicted NESs in similar
positions of their primary amino acid sequences as do the yeast
genes. Thus, one explanation for these phenomena is that
decreased MCM3 suppresses MCM2-7 nuclear export, which
occurs normally and which may be accentuated by the Chaos3
mutation in a fashion analogous to mcm mutant fission yeast
discussed above [36]. This would effectively increase the amounts
of MCMs available for replication licensing. More work is
required to determine if the rescue mechanism is indeed related
to a decrease in MCMs export, as opposed to direct or indirect
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enhanced chromatin loading.
With respect to the early lymphoma susceptibility phenotype in
Mcm4
Chaos3/Chaos3 Mcm2
Gt/+ mice, it is unclear whether the type of
tumor is dictated primarily by the particular Mcm depletion (in
this case MCM2, thus resembling Mcm2
IRES-CreERT2/IRES-CreERT2
animals), the genetic background, or the age of particular cancer
onset (if animals die of thymic lymphoma at an early age, they will
be unable to manifest later-arising mammary tumors). The
compound mutant mice used for the aging aspects of this
study were bred to at least the N3 generation in strain C3H.
Mcm4
Chaos3/Chaos3 mice congenic in this background are predis-
posed exclusively to mammary tumors, whereas lymphomas were
observed in mutants of mixed background [17]. Presently, we
favor the idea that genetic background and age of tumor type
onset are primary determinants of the cancers that arise in the
mice we have studied thus far. Genetic background has also been
reported to influence tumor latency in MCM2-deficient mice [21].
The MCM2-7 pan-reduction in Chaos3 cells is consistent with
other studies involving mutation or knockdown of a single MCM
in mammalian cells [16,20,29,37]. In these examples of parallel
MCM decreases, the general assumption is that there is hexamer
destabilization or impaired MCM chromatin loading followed by
degradation of monomers. However, we found that the protein
decreases are related to decreased mRNA levels. These large
(,40%) decreases do not appear to be attributable to transcrip-
tional alterations from cell cycle disruptions (these cells have a
small elevation in the G2/M population), but rather occur at the
post-transcriptional level (unpublished observations). Since we also
found that MEFs carrying only 1 functional Mcm2 allele caused
,20% decreases of Mcm3-7 mRNAs, it is possible that mRNA
downregulation drove MCM reductions in these other model
systems. However, the mechanism for coordinated mRNA
regulation, and what triggers it, is a mystery that we are currently
investigating.
Our data contribute to a growing body of data that replication
stress, which can occur via perturbations of the DNA replication
machinery, plays a significant role in driving cancer [38–41].
While the Mcm4
Chaos3 mutation is an unique case, the deleterious
consequences of MCM reductions suggest that genetically-based
variability in DNA replication factors can have physiological
consequences. Such variability in functions or levels may be
caused by Mendelian mutations or multigenic allele interactions.
Mutations affecting transcriptional activity of one or more Mcms,
which might occur in non-coding cis-linked sequences or unlinked
transcription factors, could have such effects. This has implications
for cancer genome resequencing projects, whereby such mutations
would not be obviously associated with MCM expression. The
allelic collection we generated, when used alone or in combination
with each other or Mcm4
Chaos3/Chaos3 mice, allow the generation of
mouse models with a graded range of MCM levels. These should
be valuable for investigations into the impact of replication
stress on animal development, cancer formation, and cellular
homeostasis.
Materials and Methods
MEF culture and proliferation assays
MEFs from 12.5- to 14.5-dpc embryos were cultured in
DMEM+10% FBS, 2 mM GlutaMAX, and penicillin-streptomy-
cin (100 units/ml). Assays were conducted on cells at early
passages (up to P3). For cell proliferation assays, 5610
4 cells were
seeded per well of a 6 well plate. They were then cultured and
harvested at the indicated time points to perform cell counts.
iPS induction from MEFs using lentiviral vectors
Doxycycline inducible lentiviral vectors [42] were prepared by
co-transecting viral packaging plasmids psPAX2 and and
pMD2.G along with vectors encoding rtTA, Oct4, Sox2, Klf4,o r
c-Myc (plasmids were obtained from Addgene.org, serial numbers
12259, 12260, 20323, 20322, 20324, and 20326) into 293T cells
using TransIT-Lt1 transfection reagent (Mirus). Viral supernatants
were collected at 48 and 72 hours, and concentrated using a 30kd
NMWL centrifugal concentrator. MEFs from 13.5d embryos, up
to P3, were seeded to gelatin coated tissue plates at a density of
6.75610
3 cells/cm
2 and allowed to attach in standard MEF media
for 24 hours before infection with lentiviral vectors. After 24 hours
incubation the culture media was changed to KO-DMEM
supplemented with 15% KO serum replacement (Gibco),
recombinant LIF, 2 mg/mL doxycycline (Sigma), 100 mm MEM
non-essential amino acids solution, 2mM GlutaMax, 100 units/
mL penicillin and 100 mg/mL streptomycin (Gibco). The
induction media was refreshed daily for 13 days until the cells
were passaged to 100 mm plates prepared with irradiated feeders.
Cells were cultured for an additional 10 days in the induction
media in the absence of doxycyline before iPS colony counting,
cell counts, and flow cytometry.
For flow cytometric quantification of iPS cells derived from
reprogramming of MEFs, ,1610
6 cells were trypsinized for
10 minutes, then washed twice with cold PBS. They were gently
but completely resuspended in 1ml of 4% paraformaldehyde in
PBS at room temperature for 30 minutes. The fixed cells were
pelleted by centrifugation at 5006G for 2 minutes and washed
twice with 10 ml TBS-TX (0.1% Triton X-100) buffer. For
antibody staining, the cells were blocked with 1ml TBS-TX buffer
with 1% BSA for 15 min at room temperature, then stained with
primary ‘‘stemness’’ antibodies (monoclonal anti-SSEA1, Milli-
pore; rabbit polyclonal anti-LIN28, Abcam) for 60 min, washed
twice, then secondary antibody was applied for 60 minutes.
Immunolabeled cells were analyzed by flow cytometry using a
488nm laser. Secondary antibodies were goat anti-mouse IgG-
FITC (South Biotech) and goat anti-rabbit IgG-594 (Molecular
Probes). Cells were considered to be iPS cells if they were LIN28/
SSEA1 positive. Calibration of the flow cytometer and gates were
set using untransfected MEFs as negative controls, and v6.4 ES
cells as positive controls.
For quantification by colony formation, plates containing the
passaged reprogrammed cells were examined microscopically at
206, and 4 fields were scored and averaged. Colonies were
considered as iPS clones based on morphological criteria: well
defined border, three-dimensionality, and tight packing of cells.
Flow cytometric analyses of micronuclei and iPS cells
Micronucleus assays, which include CD71 staining, were
performed essentially as described [43].
Nuclei isolation and immunofluorescence staining
MEFs were plated at 4610
6 cells/150 mm culture dish for
60 hr, trypsinized, then resuspended in 1ml PBS. To the
suspension was added TX-NE (320 mM sucrose, 7.5 mM MgCl2,
10 mM HEPES, 1% Triton X-100, and a protease inhibitor
cocktail). The cells were gently vortexed for 10 seconds and
incubated on ice for 30 min. Dounce homogenization was
unnecessary. Nuclei were then pelleted by centrifugation at
5006G for 2 min and washed twice with 10 ml TX-NE, then
resuspended in 1ml TX-NE. Nuclei yield and integrity was
monitored microscopically with trypan blue staining. The nuclei
were fixed by adding 15ml cold methanol for 60 min on ice. The
fixed nuclei were pelleted by centrifugation at 5006G for 2 min,
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6
nuclei were placed into 1.5ml tubes in 1ml TBS-TX buffer+1%
BSA for 15 min at room temperature. The primary antibody
(Rabbit anti-mouse MCM2) was added for 60 min, then
secondary antibody (FITC goat anti-rabbit) was added for
60 min. Finally, the nuclei were stained with propidium iodide
(PI), and RNAse treated (batches optimized empirically) for
30 mins. Immunolabeled nuclei were analyzed by flow cytometry
(using a BD FACSCalibur cytometer with CellQuest software),
exciting the PI and FITC with a 488nm laser.
Generation and validation of mouse lines bearing mutant
Mcm alleles
ES cell lines containing gene trap insertions in Mcm genes were
obtained from Bay Genomics [Mcm3 (RRR002), Mcm6 (YHD248),
Mcm7 (YTA285)] or the Sanger Institute [Mcm2 (ABO178)]. The
Mcm4 line was previously reported [17]. Allele names are
abbreviated as, for example, Mcm3
Gt instead of the full name
Mcm3
Gt(RRR002)Byg. All of the original ES cells were of strain 129
origin, and the alleles were backcrossed into C3HeB/FeJ for $4
generations.
To identify the exact insertion sites of the gene trap vectors, a
‘‘primer walking’’ procedure was used. This involved priming
PCR reactions with :1) a fixed vector primer, and 2) one of a series
of primers series corresponding to the intron in which the vector
presumably integrated. PCR products were then sequenced.
Genotyping of gene-trap-bearing mice was performed either by
PCR amplification of the neomycin resistance gene within the
vector, or by using insertion-specific assays (Table S2).
Western blot analysis
Cytosolic and chromatin-bound protein was extracted as
described [44]. Antibody binding was detected with a Pierce
ECL kit. Band were quantified using NIH Image J software.
Antibodies- aMCM2: ab31159 (Abcam); aMCM3: 4012 (Cell
Signaling); aMCM4: ab4459 (Abcam); aMCM5: NB100-78261
(Novus); aMCM6: NB100-78262 (Novus); aMCM7: ab2360
(Abcam); aBeta-actin: A1978 (Sigma); aTBP: NB500-700 (Novus).
Quantitative RT-PCR (qPCR)
Total RNA from P1 MEFs was DNAse I treated, then cDNA
was synthesized from 1 mg of total RNA using the Invitrogen
SuperScript III ReverseTranscriptase kit with the supplied Olige-
dT or random-hexamer primers. qPCR reactions were performed
in triplicate on 1 ng or 10 ng of cDNA by using the SYBR power
green RT-PCR Master kit (Applied Biosystems; 40 cycles at 95uC
for 10 s and at 60uC for 1 min), and real-time detection was
performed on an ABI PRISM 7300 and analyzed with Geneamp
5700 software. The specificity of the PCR amplification proce-
dures was checked with a heat-dissociation step (from 60uCt o
95uC) at the end of the run and by gel electrophoresis. Results
were standardized to b-actin. The PCR primers are listed in
Table S1.
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